|
Original Articles in Peer-Reviewed Journals |
|||
|
Title
|
Author(s)
|
Journal
|
Pub.
Year |
| Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. | Diaz-Gallo LM, Expino-Paisan L, Fransen K, Gomez-Garcia M, van Sommersen S, Cardena C, Rodrigo L, Mendoza JL, Taxonera C, Nieto A, Alcain G, Cueto I, Lopez-Nevot MA, Bottini N, Barclay ML, Crusis JB, van Bodegraven AA, Wijmenga C, Ponsioen CY, Gearry RB, Roberts RL, Weersma RK, Urcelay E, Merriman TR, Alizadeh BZ, Martin J. |
Inflamm Bowel Dis. | 2011 |
| PEG-modified carbon nanatubes in biomedicine: current status and challenges ahead. |
Bottini M, Rosato N, Bottini N. | Biomacromolecules. | 2011 |
| Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients. | Teruel M, Martin JE, Gonzalez-Juanatey C, Lopez-Mejias R, Miranda-Filloy JA, Blanco R, Balsa A, Pascual-Salcedo D, Rodrguez-Rodriguez L, Fernandez-Guiterrez B, Ortiz AM, Gonzalez-Alvaro I, Gomez-Vaquero C, Bottini N, Llorca J, Gonzalez-Gay MA, Martin J. |
Arthritis Res Ther. | 2011 |
| Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. | Stanford SM, Krishnamurthy D, Falk MN, Messina R, Debnath B, Li S, Liu T, Kazemi R, Dahl R, He YT, Yu XA, Chan AC, Zhang ZY, Barrios AM, Woods VL, Neamati N, Bottini N. |
J Med Chem. | 2011 |
| The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. |
Rodríguez-Rodríguez L, Taib WR, Topless R, Steer S, González-Escribano MF, Balsa A, Pascual-Salcedo D, González-Gay MA, Raya E, Fernandez-Gutierrez B, González-Álvaro I, Bottini N, Witte T, Viken MK, Coenen MJ, van Riel PL, Franke B, den Heijer M, Radstake TR, Wordsworth P, Lie BA, Merriman TR, Martín J. |
Arthritis Rheum | 2011 |
| Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. |
Fiorillo E, Orrú V, Stanford SM, Liu Y, Salek M, Rapini N, Schenone AD, Saccucci P, Delogu LG, Angelini F, Manca Bitti ML, Schmedt C, Chan AC, Acuto O, Bottini N. |
J Biol Chem |
2010 |
| Carbon nanotube-based nanocarriers: the importance of keeping it clean. |
Delogu LG, Stanford SM, Santelli E, Magrini A, Bergamaschi A, Motamedchaboki K, Rosato N, Mustelin T, Bottini N, Bottini M. |
J Nanosci Nanotechnol | 2010 |
| A study of Adenosine-Deaminase genetic polymorphism in rheumatoid arthritis. |
Sebastiani GD, Bottini N, Greco E, Saccucci P, Canu G, Lucarelli P, Gloria-Bottini F, Fontana L. | Int J Immunopathol Pharmacol |
2010 |
| Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases. |
Stanford SM, Mustelin TM, Bottini N. | Semin Immunopathol | 2010 |
| A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus. |
Saccucci P, Meloni GF, Verrotti A, Borgiani P, D'Annibale F, Giannini C, Lucarelli P, Bottini N, Chiarelli F, Bottini E, Gloria-Bottini F.
|
J Pediatr Endocrinol Metab |
2010 |
| Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase. |
Karver MR, Krishnamurthy D, Bottini N, Barrios AM. | J Inorg Biochem |
2010 |
| Type I Diabetes Genetics Consortium. rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype. |
Steck AK, Baschal EE, Jasinski JM, Boehm BO, Bottini N, Concannon P, Julier C, Morahan G, Noble JA, Polychronakos C, She JX, Eisenbarth GS; Type I Diabetes Genetics Consortium. | Genes Immun |
2009 |
| Identifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au(I) complexes. |
Karver MR, Krishnamurthy D, Kulkarni RA, Bottini N, Barrios AM. | J Med Chem |
2009 |
| Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population. |
Lamsyah H, Rueda B, Baassi L, Elaouad R, Bottini N, Sadki K, Martin J. | Tissue Antigens |
2009 |
| Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans. |
Shu YH, Hartiala J, Xiang AH, Trigo E, Lawrence JM, Allayee H, Buchanan TA, Bottini N, Watanabe RM. | J Clin Endocrinol Metab |
2009 |
| Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain. |
Liu Y, Stanford SM, Jog SP, Fiorillo E, Orrú V, Comai L, Bottini N. | Biochemistry |
2009 |
|
Crystal structure Of The Human Lymphoid Tyrosine Phosphatase Catalytic Domain: Insights Into Redox Regulation. |
Tsai SJ, Sen U, Zhao L, Greenleaf WB, Dasgupta J, Fiorillo E, Orrú V, Bottini N, Chen XS. | Biochemistry |
2009 |
| Conjugation of Antisense Oligonucleotides to PEGylated Carbon Nanotubes Enables Efficient Knockdown of PTPN22 in T Lymphocytes. |
Delogu LG, Magrini A, Bergamaschi A, Rosato N, Dawson MI, Bottini N, Bottini M. | Bioconjug Chem |
2009 |
| A loss of function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. |
Orrú V, Tsai SJ, Rueda B, Fiorillo E, Stanford SM, Dasgupta J, Hartiala J, Zhao L, Ortego-Centeno N, D'Alfonso S; Italian Collaborative Group, Arnett FC, Wu H, Gonzalez-Gay MA, Tsao BP, Pons-Estel B, Alarcon-Riquelme ME, He Y, Zhang ZY, Allayee H, Chen XS, Martin J, Bottini N. |
Hum Mol Genet | 2009 |
| Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study. |
Krishnamurthy D, Karver MR, Fiorillo E, Orrú V, Stanford SM, Bottini N, Barrios AM. | J Med Chem |
2008 |
| Association between PTPN22 C1858T and type 1 diabetes: a replication in continental Italy. |
Saccucci P, Del Duca E, Rapini N, Verrotti A, Piccinini S, Maccari A, Canu G, Angelini F, Fontana L, Giannini C, Chiarelli F, Manca Bitti ML, Bottini N. |
Tissue Antigens |
2008 |
| Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetes. |
Zoledziewska M, Perra C, Orrù V, Moi L, Frongia P, Congia M, Bottini N, Cucca F. | Diabetes |
2008 |
| Protein tyrosine phosphatase PTPN22 in human autoimmunity. |
Vang T, Miletic AV, Bottini N, Mustelin T. | Autoimmunity |
2007 |
| Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function. |
Wang Y, Vachon E, Zhang J, Cherepanov V, Kruger J, Li J, Saito K, Shannon P, Bottini N, Huynh H, Ni H, Yang H, McKerlie C, Quaggin S, Zhao ZJ, Marsden PA, Mustelin T, Siminovitch KA, Downey GP. |
J Exp Med |
2005 |
| Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. |
Vang T, Congia M, Macis MD, Musumeci L, Orrú V, Zavattari P, Nika K, Tautz L, Taskén K, Cucca F, Mustelin T, Bottini N. |
Nat Genet | 2005 |
| Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. |
Wu H, Cantor RM, Graham DS, Lingren CM, Farwell L, Jager PL, Bottini N, Grossman JM, Wallace DJ, Hahn BH, Julkunen H, Hebert LA, Rovin BH, Birmingham DJ, Rioux JD, Yu CY, Kere J, Vyse TJ, Tsao BP. | Arthritis Rheum |
2005 |
| Low-molecular-weight protein tyrosine phosphatases of Bacillus subtilis. |
Musumeci L, Bongiorni C, Tautz L, Edwards RA, Osterman A, Perego M, Mustelin T, Bottini N. |
J Bacteriol | 2005 |
| In vitro characterization of the Bacillus subtilis protein tyrosine phosphatase YwqE. |
Mijakovic I, Musumeci L, Tautz L, Petranovic D, Edwards RA, Jensen PR, Mustelin T, Deutscher J, Bottini N. |
J Bacteriol |
2005 |
| Protein tyrosine phosphatases and the immune response. |
Mustelin T, Vang T, Bottini N. |
Nat Rev Immunol | 2005 |
| Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. |
Ladner MB, Bottini N, Valdes AM, Noble JA. |
Hum Immunol |
2005 |
| Inhibition of Yersinia tyrosine phosphatase by furanyl salicylate compounds. |
Tautz L, Bruckner S, Sareth S, Alonso A, Bogetz J, Bottini N, Pellecchia M, Mustelin T. |
J Biol Chem |
2005 |
| Control of vesicle fusion by a tyrosine phosphatase. |
Huynh H, Bottini N, Williams S, Cherepanov V, Musumeci L, Saito K, Bruckner S, Vachon E, Wang X, Kruger J, Chow CW, Pellecchia M, Monosov E, Greer PA, Trimble W, Downey GP, Mustelin T. |
Nat Cell Biol | 2004 |
| Protein tyrosine phosphatases in the human genome. |
Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. |
Cell |
2004 |
| A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. |
Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. |
Nat Genet | 2004 |
| Lck dephosphorylation at Y394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH. |
Alonso A, Bottini N, Bruckner S, Rahmouni S, Williams S, Schoenberger SP, Mustelin T. |
J Biol Chem |
2004 |
Publications